| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_72a4a0bae6fe89685c930f3fb2fe1c6e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-08 |
| filingDate |
1989-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0340c6b3cc8992937b76e1821ba1c359
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9dd98b3a0a114182c5607cd6ac01b06a |
| publicationDate |
1989-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0333678-A2 |
| titleOfInvention |
Use of glycerol ethers in the treatment of allergic diseases |
| abstract |
This invention relates to use of at least one glycerol ether for a pharmaceutical preparation for treatment of allergic diseases, especiall asthma. The pharmaceutical is administered orally using capsules. The active substance comprises a mixture of glycerol ethers and is produced from shark liver. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9800120-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9741845-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2750333-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9741845-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6624191-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114502149-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008037538-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9705866-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021007623-A1 |
| priorityDate |
1988-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |